PriceTargets.com logo

Healthpeak Properties - DOC Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $22.17
  • Forecasted Upside: 2.29%
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 8 Buy Ratings
  • 1 Strong Buy Ratings
$21.67 As of 10/11/2024 01:00 AM ET
▲ +0.17 (0.79%)

This chart shows the closing price for DOC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Healthpeak Properties Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DOC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DOC

Analyst Price Target is $22.17
▲ +2.29% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Healthpeak Properties in the last 3 months. The average price target is $22.17, with a high forecast of $26.00 and a low forecast of $14.00. The average price target represents a 2.29% upside from the last price of $21.67.

This chart shows the closing price for DOC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 14 contributing investment analysts is to moderate buy stock in Healthpeak Properties. This rating has held steady since April 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 2 sell ratings
Ratings as of
4/21/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
7/20/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
10/18/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
1/16/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
4/15/2024
  • 1 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
7/14/2024
  • 1 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
9/12/2024
  • 1 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
10/12/2024

Latest Recommendations

  • 1 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/1/2024Wells Fargo & CompanyReiterated RatingEqual Weight ➝ Equal Weight$22.00 ➝ $23.00
9/16/2024Evercore ISIBoost TargetOutperform ➝ Outperform$25.00 ➝ $26.00
9/9/2024ScotiabankBoost TargetSector Outperform ➝ Sector Outperform$23.00 ➝ $24.00
8/28/2024Evercore ISIBoost TargetOutperform ➝ Outperform$24.00 ➝ $25.00
8/22/2024CitigroupBoost TargetNeutral ➝ Neutral$20.00 ➝ $22.00
8/12/2024Wells Fargo & CompanyUpgradeHold
7/30/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$22.00 ➝ $25.00
7/29/2024Evercore ISIUpgradeStrong-Buy
7/29/2024WedbushBoost TargetOutperform ➝ Outperform$22.00 ➝ $25.00
5/16/2024ScotiabankBoost TargetSector Outperform ➝ Sector Outperform$22.00 ➝ $23.00
5/16/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$19.00 ➝ $21.00
5/9/2024ArgusUpgradeStrong-Buy
5/3/2024WedbushUpgradeNeutral ➝ Outperform
4/26/2024BNP ParibasUpgradeNeutral ➝ Outperform$19.00 ➝ $21.00
4/22/2024MizuhoReiterated RatingBuy$22.00
4/10/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$21.00 ➝ $22.00
4/1/2024Bank of AmericaUpgradeUnderperform ➝ Buy$18.00 ➝ $25.00
3/25/2024Wells Fargo & CompanyInitiated CoverageEqual Weight$19.00
3/8/2024Royal Bank of CanadaInitiated CoverageOutperform$21.00
1/5/2024KeyCorpReiterated RatingOverweight ➝ Sector Weight
1/2/2024Compass PointLower TargetBuy ➝ Buy$19.00 ➝ $18.00
12/22/2023Truist FinancialLower TargetHold ➝ Hold$15.00 ➝ $14.00
8/22/2023CitigroupLower TargetNeutral ➝ Neutral$15.00 ➝ $14.00
8/16/2023Truist FinancialReiterated RatingHold ➝ Hold$15.00
8/7/2023Wells Fargo & CompanyBoost TargetUnderweight ➝ Underweight$14.00 ➝ $15.00
7/20/2023Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$14.50
5/26/2023JMP SecuritiesInitiated CoverageOutperform$15.50
5/5/2023BarclaysLower Target$18.00 ➝ $17.00
4/19/2023Wells Fargo & CompanyInitiated CoverageUnderweight$14.00
3/29/2023Credit Suisse GroupReiterated RatingNeutral$15.00
3/27/2023Compass PointLower TargetBuy$21.00 ➝ $19.00
2/28/2023Royal Bank of CanadaLower TargetSector Perform$16.00 ➝ $15.00
12/14/2022KeyCorpUpgradeSector Weight ➝ Overweight$17.00
11/1/2022Morgan StanleyLower TargetEqual Weight$16.50 ➝ $14.50
10/28/2022JPMorgan Chase & Co.Initiated CoverageNeutral$17.00
8/31/2022Morgan StanleyBoost TargetEqual Weight$16.00 ➝ $16.50
8/22/2022CitigroupBoost Target$19.00
8/5/2022Colliers SecuritiesDowngradeBuy ➝ Neutral$19.00
7/15/2022Morgan StanleyLower TargetEqual Weight$17.50 ➝ $16.00
7/11/2022Truist FinancialLower TargetHold$18.00 ➝ $17.00
6/30/2022Jefferies Financial GroupLower TargetBuy$21.00 ➝ $20.00
6/3/2022Capital One FinancialInitiated CoverageEqual Weight ➝ Equal Weight$20.00
6/1/2022Morgan StanleyLower TargetEqual Weight$18.00 ➝ $17.50
5/19/2022Bank of AmericaDowngradeNeutral ➝ Underperform$18.00
4/26/2022BarclaysInitiated CoverageOverweight$20.00
3/9/2022Royal Bank of CanadaLower TargetSector Perform$19.00 ➝ $18.00
3/7/2022Morgan StanleyLower TargetEqual Weight$19.00 ➝ $18.00
2/24/2022Colliers SecuritiesReiterated RatingBuy$20.00
2/1/2022Credit Suisse GroupInitiated CoverageNeutral$19.00
1/7/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$20.00
11/29/2021Morgan StanleyLower TargetEqual Weight$20.00 ➝ $19.00
10/7/2021BMO Capital MarketsBoost TargetMarket Perform$32.50 ➝ $35.00
9/13/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$20.00
8/20/2021Raymond JamesDowngradeOutperform ➝ Market Perform
7/16/2021Colliers SecuritiesReiterated RatingBuy$21.00
6/14/2021Robert W. BairdDowngradeOutperform ➝ Neutral$19.00 ➝ $20.00
3/15/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$20.00
1/13/2021Jefferies Financial GroupUpgradeHold ➝ Buy$18.00 ➝ $20.00
12/11/2020Morgan StanleyBoost TargetEqual Weight$14.00 ➝ $16.00
11/11/2020B. RileyReiterated RatingBuy
11/11/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$20.00
9/9/2020Colliers SecuritiesInitiated CoverageBuy$22.00
8/31/2020Raymond JamesBoost TargetOutperform$19.00 ➝ $20.00
8/7/2020KeyCorpBoost TargetOverweight$18.00 ➝ $20.00
7/2/2020CitigroupBoost TargetNeutral$14.00 ➝ $18.00
6/10/2020B. RileyBoost Target$19.00 ➝ $21.00
5/8/2020B. RileyLower TargetBuy$22.00 ➝ $19.00
4/29/2020Raymond JamesLower TargetOutperform$22.00 ➝ $19.00
4/23/2020SunTrust BanksLower TargetHold$19.00 ➝ $16.00
4/21/2020KeyCorpLower TargetOverweight$22.00 ➝ $18.00
4/7/2020CitigroupDowngradeBuy ➝ Neutral$21.00 ➝ $14.00
4/1/2020Berenberg BankUpgradeHold ➝ Buy
3/30/2020MizuhoDowngradeHold
3/26/2020Morgan StanleyLower TargetEqual Weight$18.00 ➝ $14.00
3/16/2020BTIG ResearchDowngradeBuy ➝ Neutral
3/12/2020Raymond JamesBoost TargetOutperform$20.00 ➝ $22.00
3/9/2020Royal Bank of CanadaReiterated RatingBuy$22.00
3/9/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$19.00 ➝ $23.00
2/27/2020Capital One FinancialUpgradeEqual Weight ➝ Overweight$18.50 ➝ $22.00
2/27/2020B. RileyBoost TargetBuy$20.00 ➝ $22.00
1/16/2020KeyCorpBoost TargetOverweight$19.00 ➝ $20.00
12/19/2019MizuhoInitiated CoverageBuy$20.00
12/12/2019CitigroupUpgradeNeutral ➝ Buy$18.50 ➝ $21.00
11/26/2019Stifel NicolausUpgradeHold ➝ Buy$19.00 ➝ $21.00
11/8/2019B. RileyReiterated RatingBuy
10/14/2019Bank of AmericaInitiated CoverageNeutral
(Data available from 10/12/2019 forward)

News Sentiment Rating

0.79 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 20 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/16/2024
  • 8 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/15/2024
  • 14 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/15/2024
  • 19 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/14/2024
  • 7 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/14/2024
  • 7 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/13/2024
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/12/2024
  • 9 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
10/12/2024

Current Sentiment

  • 9 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Healthpeak Properties logo
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

Today's Range

Now: $21.67
Low: $21.53
High: $21.74

50 Day Range

MA: $22.05
Low: $20.75
High: $22.87

52 Week Range

Now: $21.67
Low: $15.24
High: $23.14

Volume

3,460,504 shs

Average Volume

5,711,117 shs

Market Capitalization

$15.25 billion

P/E Ratio

46.11

Dividend Yield

5.51%

Beta

1.14

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthpeak Properties?

The following Wall Street analysts have issued research reports on Healthpeak Properties in the last year: Argus, Bank of America Co., BNP Paribas, Citigroup Inc., Compass Point, Evercore ISI, JPMorgan Chase & Co., KeyCorp, Mizuho, Royal Bank of Canada, Scotiabank, StockNews.com, Truist Financial Co., Wedbush, and Wells Fargo & Company.
View the latest analyst ratings for DOC.

What is the current price target for Healthpeak Properties?

12 Wall Street analysts have set twelve-month price targets for Healthpeak Properties in the last year. Their average twelve-month price target is $22.17, suggesting a possible upside of 2.3%. Evercore ISI has the highest price target set, predicting DOC will reach $26.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $14.00 for Healthpeak Properties in the next year.
View the latest price targets for DOC.

What is the current consensus analyst rating for Healthpeak Properties?

Healthpeak Properties currently has 5 hold ratings, 8 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for DOC.

What other companies compete with Healthpeak Properties?

Other companies that are similar to Healthpeak Properties include Ares Management, Blue Owl Capital, Texas Pacific Land, Robinhood Markets and TPG. Learn More about companies similar to Healthpeak Properties.

How do I contact Healthpeak Properties' investor relations team?

Healthpeak Properties' physical mailing address is 309 N. WATER STREET SUITE 500, MILWAUKEE WI, 53202. The real estate investment trust's listed phone number is (414) 367-5600 and its investor relations email address is [email protected]. The official website for Healthpeak Properties is www.docreit.com. Learn More about contacing Healthpeak Properties investor relations.